SCHEMBL2483526

SCHEMBL2483526

CC(C)(C)c1cc(OC(=O)c2ccccc2)c(OC(=O)c2ccccc2)c(-c2ccccc2)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.51
TDP1 Q9NUW8 2/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
NPSR1 Q6W5P4 2/20 0.44
RXRA P19793 1/20 0.43
RXRB P28702 1/20 0.43
KMT2A Q03164 3/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
BACE1 P56817 2/20 0.41
SLC6A3 Q01959 1/20 0.41
TNF P01375 1/20 0.40
KLF5 Q13887 1/20 0.40
NOD1 Q9Y239 1/20 0.40
EGFR P00533 1/20 0.40
ESR1 P03372 1/20 0.40
ESR2 Q92731 1/20 0.40
ALDH1A1 P00352 2/20 0.39
TSHR P16473 1/20 0.39
HSD17B10 Q99714 1/20 0.39
MEN1 O00255 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2888364 0.86 MAPT (0.40) MAPTTDP1L3MBTL1NPSR1KMT2A
SCHEMBL498389 0.85 MAPT (0.55) MAPTTDP1L3MBTL1NPSR1KMT2A
SCHEMBL2882461 0.83 MAPT (0.54) MAPTTDP1L3MBTL1NPSR1KMT2A
SCHEMBL2509862 0.83 MAPT (0.50) MAPTTDP1L3MBTL1NPSR1KMT2A
SCHEMBL2482056 0.82 KMT2A (0.45) MAPTNPSR1KMT2ASMN1; SMN2BACE1
SCHEMBL2508951 0.81 MAPT (0.47) MAPTTDP1NPSR1KMT2ASMN1; SMN2
SCHEMBL2510166 0.81 MAPT (0.51) MAPTTDP1L3MBTL1NPSR1KMT2A
SCHEMBL2482165 0.80 KMT2A (0.46) MAPTTDP1L3MBTL1NPSR1RXRA
SCHEMBL2882737 0.78 KMT2A (0.42) MAPTTDP1NPSR1KMT2ASMN1; SMN2
SCHEMBL2478898 0.78 NPSR1 (0.50) MAPTTDP1L3MBTL1NPSR1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8604235-B2 Production of substituted phenylene aromatic diesters and compositions DOW GLOBAL TECHNOLOGIES LLC (US) 2013-12-10 US disclosed
EP-2376423-A1 PRODUCTION OF SUBSTITUTED PHENYLENE AROMATIC DIESTERS Dow Global Technologies LLC (US) 2011-10-19 EP disclosed
US-20100204506-A1 Production of Substituted Phenylene Aromatic Diesters and Compositions W. R. GRACE & CO.-CONN. 2010-08-12 US disclosed
WO-2010078519-A1 PRODUCTION OF SUBSTITUTED PHENYLENE AROMATIC DIESTERS DOW GLOBAL TECHNOLOGIES INC. (US) 2010-07-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100204506-A1 Production of Substituted Phenylene Aromatic Diesters and Compositions PAH, DDC, DDT MAPT 2384/4885TDP1 1529/4885L3MBTL1 2786/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.